首页> 美国卫生研究院文献>International Journal of Oncology >Microarray phosphatome profiling of breast cancer patients unveils a complex phosphatase regulatory role of the MAPK and PI3K pathways in estrogen receptor-negative breast cancers
【2h】

Microarray phosphatome profiling of breast cancer patients unveils a complex phosphatase regulatory role of the MAPK and PI3K pathways in estrogen receptor-negative breast cancers

机译:乳腺癌患者的微阵列磷原子分析揭示了雌激素受体阴性乳腺癌中MAPK和PI3K途径的复杂磷酸酶调节作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Phosphatases are proteins with the ability to dephosphorylate different substrates and are involved in critical cellular processes such as proliferation, tumor suppression, motility and survival. Little is known about their role in the different breast cancer (BC) phenotypes. We carried out micro-array phosphatome profiling in 41 estrogen receptor-negative (ER) BC patients, as determined by immunohistochemistry (IHC), containing both ERBB2+ and ERBB2 in order to characterize the differences between these two groups. We characterized and confirmed the distinct phosphatome of the two main ER BC subgroups (in two independent microarrays series) and that of ER+ BC (in three large independent series). Our findings point to the importance of the MAPK and PI3K pathways in ER BCs as some of the most differentially expressed phosphatases (like DUSP4 and DUSP6) sharing ERK as substrate, or regulating the PI3K pathway (INPP4B, PTEN). It was possible to identify a selective group of phosphatases upregulated only in the ER ERBB2+ subgroup and not in ER+ (like DUSP6, DUSP10 and PPAPDC1A among others), suggesting a role of these phosphatases in specific BC subtypes, unlike other differentially expressed phosphatases (DUSP4 and ENPP1) that seemed to have a role in multiple BC subtypes. Significant correlation was found at the protein level by IHC between the expression of DUSP6 and phospho-ERK (p=0.04) but not of phospho-ERK with DUSP4. To show the potential prognostic relevance of phosphatases as a functional group of genes, we derived and validated in two large independent BC microarray series a multiphosphatase signature enriched in differentially expressed phosphatases, to predict distant metastasis-free survival (DMFS). ER ERBB2+, ER ERBB2 and ER+ BC patients have a distinct pattern of phosphatase RNA expression with a potential prognostic relevance. Further studies of the most relevant phosphatases found in this study are warranted.
机译:磷酸酶是具有使不同底物脱磷酸的能力的蛋白质,并且参与关键的细胞过程,例如增殖,肿瘤抑制,运动性和存活。关于它们在不同乳腺癌(BC)表型中的作用鲜为人知。根据免疫组织化学(IHC)的测定,我们对41位雌激素受体阴性(ER -)BC患者进行了微阵列磷酸化分析,其中包含ERBB2 + 和ERBB2 < sup>-,以表征这两组之间的差异。我们表征并确认了两个主要的ER - BC亚组(在两个独立的微阵列系列中)和ER + BC(在三个大的独立系列中)的不同磷原子。我们的研究结果指出,ER - BC中MAPK和PI3K途径的重要性,因为一些差异最大的磷酸酶(如DUSP4和DUSP6)以ERK为底物或调节PI3K途径(INPP4B, PTEN)。可以鉴定仅在ER - ERBB2 + 子组而不是ER + 子组中上调的磷酸酶选择性组(如DUSP6,DUSP10和PPAPDC1A等),表明这些磷酸酶在特定的BC亚型中的作用,与其他差异表达的磷酸酶(DUSP4和ENPP1)似乎在多种BC亚型中起作用不同。在IHC的蛋白质水平上,DUSP6和磷酸化ERK的表达之间存在显着相关性(p = 0.04),而磷酸化ERK与DUSP4的表达则没有相关性。为了显示磷酸酶作为基因功能组的潜在预后相关性,我们在两个大型独立的BC微阵列系列中获得并验证了富含差异表达的磷酸酶的多磷酸酶标记,以预测无远处转移的生存期(DMFS)。 ER - ERBB2 + ,ER - ERBB2 -和ER + BC患者磷酸酶RNA表达的独特模式与潜在的预后相关性。有必要对这项研究中发现的最相关的磷酸酶进行进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号